|
US2010143325A1
|
|
Composition And Methods Involving Thrombolytic Agents
|
|
EP0682700A1
|
|
Use of intra-platelet urokinase-type plasminogen activators for long-term inhibition of thrombosis.
|
|
IL94064D0
|
|
Plasminogen activator complex of pure pro-urokinase covalently bound by a disulfide bridge to human serum albumin
|
|
IE901349L
|
|
Plasminogen activator complex of pro-urokinase and serum¹albumin
|
|
EP0395918A2
|
|
Plasminogen activator complex of pure pro-urokinase covalently bound by a disulfide bridge to human serum albumin
|
|
FI901810A0
|
|
Plasminogen-aktivatorkomplex av rent pro-urokinas, bundet till humant serumalbumin medelst en disulfidbrygga.
|
|
SG40587G
|
|
Plasminogen activators useful as therapeutic and diagnostic agents and their isolation
|
